Product Data Sheet

Itacitinib adipate

Catalog No. A33274

main product photo
Itacitinib adipate is a selective JAK1 inhibitor that exhibits oral bioavailability. This compound has demonstrated efficacy and safety in phase II clinical trials for the treatment of myelofibrosis. Its mechanism of action, targeting the JAK1 pathway, makes it a valuable tool for research in hematological malignancies and associated signaling pathways.
Chemical Information
Catalog NumA33274
M. Wt699.66
FormulaC32H33F4N9O5
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.1334302-63-4
Synonyms
SMILESN#CCC1(N2N=CC(C3=C4C(NC=C4)=NC=N3)=C2)CN(C5CCN(C(C6=C(F)C(C(F)(F)F)=NC=C6)=O)CC5)C1.O=C(O)CCCCC(O)=O
Biological Activity
DescriptionItacitinib adipate is a selective JAK1 inhibitor that exhibits oral bioavailability. This compound has demonstrated efficacy and safety in phase II clinical trials for the treatment of myelofibrosis. Its mechanism of action, targeting the JAK1 pathway, makes it a valuable tool for research in hematological malignancies and associated signaling pathways.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.